E-therapeutics Plc
ETXPF · OTC
1/31/2025 | 1/31/2024 | 1/31/2023 | 1/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $21 | $21 | $32 | $15 |
| Short-Term Investments | $12 | $0 | $0 | $20 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4 | $3 | $2 | $2 |
| Total Curr. Assets | $37 | $24 | $42 | $38 |
| Property Plant & Equip (Net) | $1 | $1 | $0 | $1 |
| Goodwill | $0 | $0 | -$0 | $0 |
| Intangibles | $1 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | -$0 | $0 |
| Total NC Assets | $2 | $1 | $1 | $1 |
| Other Assets | $0 | $0 | -$8 | $0 |
| Total Assets | $38 | $25 | $35 | $40 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $0 | $0 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1 | $1 | $1 | $1 |
| Total Curr. Liab. | $2 | $3 | $2 | $2 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $1 | $0 | $1 |
| Total Liabilities | $2 | $3 | $2 | $2 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $1 | $1 |
| Retained Earnings | -$106 | -$91 | -$80 | -$97 |
| AOCI | $0 | $0 | -$0 | $0 |
| Other Equity | $141 | $113 | $120 | $124 |
| Total Equity | $36 | $22 | $41 | $37 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $38 | $25 | $35 | $40 |
| Net Debt | -$20 | -$20 | -$31 | -$15 |